0001209191-18-031892.txt : 20180521
0001209191-18-031892.hdr.sgml : 20180521
20180521164044
ACCESSION NUMBER: 0001209191-18-031892
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180517
FILED AS OF DATE: 20180521
DATE AS OF CHANGE: 20180521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hagan Joseph P
CENTRAL INDEX KEY: 0001465278
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35670
FILM NUMBER: 18850165
MAIL ADDRESS:
STREET 1: 3344 N. TORREY PINES COURT, SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Regulus Therapeutics Inc.
CENTRAL INDEX KEY: 0001505512
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264738379
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10614 SCIENCE CENTER DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-202-6300
MAIL ADDRESS:
STREET 1: 10614 SCIENCE CENTER DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-05-17
0
0001505512
Regulus Therapeutics Inc.
RGLS
0001465278
Hagan Joseph P
C/O REGULUS THERAPEUTICS INC.
10614 SCIENCE CENTER DRIVE
SAN DIEGO
CA
92121
1
1
0
0
President and CEO
Stock Option (Right to Buy)
0.71
2018-05-17
4
A
0
725000
0.00
A
2028-05-16
Common Stock
725000
725000
D
The option will vest in forty-eight equal monthly installments, such that the option will be fully vested four years from the date of grant, subject to the Reporting Person's continuous service to us.
Christopher Aker, Attorney in Fact
2018-05-21